These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7566579)

  • 1. Immunological determination of advanced glycosylation end-products in human blood and urine.
    Dolhofer-Bliesener R; Lechner B; Deppisch R; Ritz E; Gerbitz KD
    Nephrol Dial Transplant; 1995; 10(5):657-64. PubMed ID: 7566579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K; Podracká L; Heidland A; Schinzel R
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of increased serum advanced glycosylation end products in patients with end stage renal disease by hemodialysis.
    Liu NF; Sun ZL; Liu BC
    Acta Pharmacol Sin; 2000 Mar; 21(3):276-80. PubMed ID: 11324431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
    Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
    Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end product is implicated in amyloid-related kidney complications.
    Matsunaga N; Anan I; Rosenberg P; Nagai R; Lundström O; Horiuchi S; Ando Y; Suhr OB
    Scand J Clin Lab Invest; 2005; 65(4):263-71. PubMed ID: 16076681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of glycated nucleobases in human urine by a new monoclonal antibody specific for N2-carboxyethyl-2'-deoxyguanosine.
    Schneider M; Thoss G; Hübner-Parajsz C; Kientsch-Engel R; Stahl P; Pischetsrieder M
    Chem Res Toxicol; 2004 Oct; 17(10):1385-90. PubMed ID: 15487900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
    Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
    Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Products of advanced glycation in patients with type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Pokupec R; Turk N; Stavljenić-Rukavina A
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of advanced glycation end products in children with renal disease.
    Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
    Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.
    Mitsuhashi T; Li YM; Fishbane S; Vlassara H
    J Clin Invest; 1997 Aug; 100(4):847-54. PubMed ID: 9259584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation.
    Yoshida S; Yamada K; Hamaguchi K; Nishimura M; Hatakeyama E; Tsuchida H; Sakamoto K; Kashiwabara H; Yokoyama T; Ikeda K; Horiuchi S
    Clin Nephrol; 1998 May; 49(5):273-80. PubMed ID: 9617488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a diet rich in advanced glycation end products in the rat remnant kidney model.
    Sebeková K; Faist V; Hofmann T; Schinzel R; Heidland A
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S48-51. PubMed ID: 12612952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advanced glycosylation end products or glycotoxins: under-evaluated components of diet?].
    Wautier JL
    Rev Prat; 2001 Sep; 51(13):1397-9. PubMed ID: 11601066
    [No Abstract]   [Full Text] [Related]  

  • 19. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between autofluorescence and advanced glycation end products in diabetic lenses.
    Abiko T; Abiko A; Ishiko S; Takeda M; Horiuchi S; Yoshida A
    Exp Eye Res; 1999 Mar; 68(3):361-6. PubMed ID: 10079144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.